Backtesting Strategies and Pitfalls

From Theory to Evidence

Welcome to the final pillar of our protocol: Backtesting. In value investing, we move from the theory of 'low P/E is good' to the evidence of how that specific rule performed over decades. Please note: This lesson is for educational purposes only and does not constitute financial advice. Simulated performance has inherent limitations and may not reflect actual trading results. Let's explore how we turn historical data into a diagnostic tool for your strategy.

The Ghost in the Machine: Survivorship Bias

Survivorship bias is the most common way to accidentally 'cheat' in a backtest. If you test a strategy today using only the current S&P 500 constituents, you are looking at the survivors of the last 20 years. You miss the value stocks that went bankrupt, like Lehman Brothers. This creates a 'survivor's premium' that doesn't exist in the real world.

Trading with Tomorrow's News: Look-Ahead Bias

Look-ahead bias occurs when your simulation 'knows' the future. Imagine buying a stock on January 1st based on its December 31st earnings. In reality, those earnings aren't public until February or March. To fix this, we use Point-in-Time data, ensuring the model only acts on information available at the exact moment of the trade.

The Sin of Overfitting

Overfitting is the 'original sin' of quantitative finance. If you add enough filters—like 'only buy if P/E is exactly 12.5'—you can make any historical curve look like a straight line up. But because you've 'memorized' the past noise, the strategy will likely crash when it hits new, unseen data. Remember: Simplicity is a feature, not a bug.

Recap: The Three Deadly Biases

Before we move to the robust design workflow, let's review the biases that lead to 'paper profits' but real-world losses. Click each term to refresh your memory on why these pitfalls are so dangerous for systematic value investors.

Spot the Bias

Look at this backtest setup. The investor is testing a high-quality value strategy on the current S&P 500 members back to 2005. Which bias is primarily inflating these results? Not quite. While reporting lag is a risk, the primary issue here is the 'Current' list of stocks, which creates Survivorship Bias. Correct! By using 'Current Constituents,' they've ignored every company that failed or was delisted between 2005 and today. This makes the strategy look much safer than it was.

Robust Workflow: Steps 1 to 3

To avoid these traps, follow a rigorous 5-step workflow. First, define a broad, bias-free universe that includes companies that no longer exist. Second, establish precise entry and exit rules. Third, apply Point-in-Time constraints to account for reporting lags.

Robust Workflow: Steps 4 and 5

The final steps bridge the gap to reality. Step four: Factor in frictions. Commissions and slippage are the 'silent killers' of small-cap value strategies. Finally, use Out-of-Sample testing. Divide your data: build on one half, and test on the other. If it fails on the unseen data, it was overfit.

The Hidden Killers: Liquidity and Noise

Even a bias-free backtest can be misleading. Liquidity is key: if your trade size is too large for the stock's volume, you'll destroy your own edge. Beware of the 'Multiple Testing' trap—if you try 1,000 combinations, one will look like a 'holy grail' purely by chance.

Recap: Robust Backtesting

We've covered the workflow and the final pitfalls. A backtest is a diagnostic tool, not a crystal ball—it tells you if an edge *existed*, not if it *will* exist. Review these takeaways before the final evaluation.

Strategy Diagnostic

Analyze this investor's backtest. Why is his 30% return likely a 'paper profit' rather than a real edge? Type your diagnosis and submit.